Summary
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
Register to download
Persistence Leads To High Enrollment
You may also be interested in:
page
The Center for Pediatric Clinical Development
We’re powering innovation in pediatric clinical trial design and implementation—because half isn’t whole. 70% of the medicines given to children have…
Read More
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
View Resource
page
About PRA Health Sciences
We are a global healthcare intelligence partner, consistently ranked among the top CROs and best employers worldwide.
Read More
View all related content and resources for Clinical Development
Explore Insights